The American Diabetes Association (ADA) 85th Scientific Sessions was held in Chicago, Illinois from June 20-June 23, 2025 and featured the latest data from current therapeutic interventions and drug candidates for type 1 and type 2 diabetes, and obesity. Key data presented included the latest results of numerous glucagon-like peptide 1 (GLP-1)-based therapies for type II diabetes and obesity.

This post-meeting report features commentary from our analysts on specific presentations. It also includes a compilation of data events added in conjunction with the meeting.